Reason for request
Inclusion
Clinical Benefit
| Substantial |
The actual benefit is substantial in the indication in the Marketing Authorisation. |
Clinical Added Value
| no clinical added value |
DEXDOR does not offer any improvement in actual benefit (non-existent IAB) in comparison with propofol and midazolam in the light to moderate sedation of adults in intensive care units. |
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
WhaBCjyjD7ugbCGZ
